Dr Marianne Brodmann (Professor of Vascular Medicine, Medical University of Graz, Graz, Austria) discusses the challenges, treatment and developments in antithrombotic therapy in patients with lower extremity arterial disease (LEAD).
Filmed at ESC 2018, Munich.
View more content here.
Speaker Disclosure: Dr Marianne Brodmann has nothing to disclose in relation to this video interview.
Questions:
1. Please describe the current challenges of treating lower extremity arterial disease (LEAD) compared with other forms of atherosclerotic cardiovascular disease? (0:09)
2. How do you currently treat patients with LEAD? (1:32)
3. What are the treatment goals for patients receiving antithrombotic therapy to treat LEAD? (2:29)
4. What recent developments have there been in the treatment of LEAD, particularly concerning the use of antithrombotic therapy? (3:13)
5. What further research is currently ongoing and planned to assess the benefit of antithrombotic therapy in LEAD? (4:09)
touchCARDIO.com is an independent information resource supporting physicians, clinicians and leading industry professionals in continuously developing their knowledge, effectiveness and productivity, via open-access content in multimedia formats.
